ScholarIQanswers from OpenAlex & ORCID
Ajay K. Kakkar
ResearcherPublications, citations & collaboration network
Ajay K. Kakkar is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Ajay K. Kakkar have?
ScholarIQindexed works
Ajay K. Kakkar has 310 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Ajay K. Kakkar have?
ScholarIQcitation count
Ajay K. Kakkar has 41,003 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Ajay K. Kakkar?
ScholarIQh-index
Ajay K. Kakkar has an h-index of 72 in OpenAlex.
What is the i10-index of Ajay K. Kakkar?
ScholarIQi10-index
Ajay K. Kakkar has an i10-index of 174 in OpenAlex.
What is the ORCID of Ajay K. Kakkar?
ScholarIQorcid
The ORCID for Ajay K. Kakkar is on the source record.
What is the OpenAlex record for Ajay K. Kakkar?
ScholarIQopenalex
The OpenAlex for Ajay K. Kakkar is on the source record.
What are the most-cited papers on Ajay K. Kakkar?
ScholarIQmost cited works
Rivaroxaban with or without Aspirin in Stable Cardiovascular Disease
John W. Eikelboom, Stuart J. Connolly, Jackie Bosch, Gilles R. Dagenais, Robert G. Hart, Olga Shestakovska, Rafael Díaz, Marco Alings, Eva Lonn, Sonia S. Anand, Petr Widimský, Masatsugu Hori, Álvaro Avezum, Leopoldo Soares Piegas, Kelley R. Branch, Jeffrey L. Probstfield, Deepak L. Bhatt, Jun Zhu, Yan Liang, Aldo P. Maggioni, Patricio López‐Jaramillo, Martin O’Donnell, Ajay K. Kakkar, Keith A.A. Fox, Alexander Parkhomenko, Georg Ertl, Stefan Störk, Mátyás Keltai, Lars Rydén, Nana Pogosova, Antonio L Dans, Fernando Laņas, Patrick Commerford, Christian Torp‐Pedersen, Tomek J. Guzik, Peter Verhamme, Dragoş Vinereanu, Jae‐Hyung Kim, Andrew M. Tonkin, Basil S. Lewis, Camilo Félix, Khalid Yusoff, Philippe Gabríel Steg, Kaj Metsärinne, Nancy Cook Bruns, Frank Misselwitz, Edmond Chen, Darryl P. Leong, Salim Yusuf
Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease: an international, randomised, double-blind, placebo-controlled trial
Sonia S. Anand, Jackie Bosch, John W. Eikelboom, Stuart J. Connolly, Rafael Díaz, Peter Widimsky, Victor Aboyans, Marco Alings, Ajay K. Kakkar, Katalin Keltai, Aldo P. Maggioni, Basil S. Lewis, Stefan Störk, Jun Zhu, Patricio López‐Jaramillo, Martin O’Donnell, Patrick Commerford, Dragoş Vinereanu, Nana Pogosova, Lars Rydén, Keith A.A. Fox, Deepak L. Bhatt, Frank Misselwitz, George Varigos, Thomas Vanassche, Álvaro Avezum, Edmond Chen, Kelley R. Branch, Darryl P. Leong, Shrikant I. Bangdiwala, Robert G. Hart, Salim Yusuf, JORGELINA SALA, Luis R Cartasegna, MARISA VICO, Miguel Hominal, Eduardo Hasbani, Alberto Caccavo, Cesar Javier Zaidman, DANIEL VOGEL, Adrian D. Hrabar, Pablo Schygiel, Carlos Alberto Cuneo, Hugo A Luquez, Ignacio MacKinnon, Rodolfo Andrés Ahuad Guerrero, Juan Pablo Costabel, INES PALMIRA BARTOLACCI, Oscar Montaña, María Antonietta Barbieri, Oscar Gómez Vilamajó, RUBEN OMAR GARCIA DURAN, Lilia Beatriz Schiavi, Marcelo Garrido, ADRIAN INGARAMO, Anselmo P. Bordonava, MARIA JOSE PELAGAGGE, LEONARDO NOVARETTO, JUAN PABLO ALBISU DI GENNERO, LUZ MARIA IBANEZ SAGGIA, MOIRA ALVAREZ, Néstor A. Vita, Stella M. Macı́n, Ricardo D. Dran, Marcelo Cardona, Luis Guzman, RODOLFO JUAN SARJANOVICH, Jesus Cuadrado, SEBASTIAN NANI, MARCOS RAUL LITVAK BRUNO, Carolina Chacón, Laura Maffei, Diego Grinfeld, NATALIA VENSENTINI, CLAUDIO RODOLFO MAJUL, Héctor Luciardi, PATRICIA DEL CARMEN GONZALEZ COLASO, FREDY ANTONI FERRE PACORA, PAUL VAN DEN HEUVEL, Peter Verhamme, Bavo Ector, PHILIPPE DEBONNAIRE, Philippe van de Borne, JEAN LEROY, Herman Schroë, Pascal Vranckx, Ivan Elegeert, E Hoffer, KARL DUJARDIN, CLARISSE INDIO DO BRASIL, Dalton Bertolim Précoma, JOSE ANTONIO ABRANTES, Euler Roberto Fernandes Manenti, Gilmar Reis, José Francisco Kerr Saraiva, Lília Nigro Maia, Mauro Esteves Hernandes, Paulo Roberto Ferreira ROSSI, Fabio Rossi dos Santos, Sérgio Luiz Zimmermann
Rivaroxaban for Thromboprophylaxis in High-Risk Ambulatory Patients with Cancer
Alok A. Khorana, Gerald A. Soff, Ajay K. Kakkar, Saroj Vadhan‐Raj, Hanno Riess, Ted Wun, Michael B. Streiff, David García, Howard A. Liebman, Chandra P. Belani, Eileen M. O’Reilly, Jai N. Patel, Habte Yimer, Peter Wildgoose, Paul Burton, Ujjwala Vijapurkar, Simrati Kaul, John W. Eikelboom, Robert D. McBane, Kenneth A. Bauer, Nicole M. Kuderer, Gary H. Lyman
2019 international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer
Dominique Farge, Corinne Frère, Jean M. Connors, Cihan Ay, Alok A. Khorana, Andrés J. Muñoz Martín, Benjamin Brenner, Ajay K. Kakkar, Hanadi Rafii, Susan Solymoss, Dialina Brilhante, Manuel Monréal, Henri Bounameaux, Ingrid Pabinger, James D. Douketis, Walter Ageno, Fernando Ajauro, Kamal R. Al-Aboudi, Thierry Alcindor, Thierry André, Pantep Angchaisuksiri, Darko Antić, Juan I. Arcelus, Eric Assénat, Kenneth A. Bauer, Ali Bazarbachii, Ilham Benzidia, Jan Beyer‐Westendorf, Viktoria Bitsadze, Dorit Blickstein, Mark Blostein, Isabel Bogalho, Barbara Bournet, Patricia Casais, Alain Carpentier, Gabriela Cesarman‐Maus, Joydeep Chakbrabartty, Hugo Clemente, J. Connault, Ludovic Doucet, C. Durant, Joseph Emmerich, Anna Falanga, Clemens Feistritzer, Carme Font, Charles W. Francis, Enrique Gallardo, Thomas Gary, Jean‐Christophe Gris, Cecilia Guillermo, A. Hij, Russel Hull, Takayuki Ikezoe, Luis Jara‐Palomares, Nigel S. Key, Jamilya Khrizroeva, Maral Koolian, Florian Länger, C. Le Hello, Ramón Lecumberri, Lai Heng Lee, Howard A. Liebman, Luisa Lopes Dos Santos, Duarte Machado, Isabelle Madelaine, А. D. Makatsariya, Mario Mandalà, Anthony Marayevas, Zora Marjanovic, Christine Marosi, Ellis Martin, Luis Meillón, E. Messas, António Moreira, Ahmet Muzaffer Demir, Arlette Ndour, Michel N'Guessan, Remedios Otero, Vanessa Pachón Olmos, Ana Pais, Florian Posch, Matthias Preusser, H. Riess, Marc Righini, Cynthia Rothschild, André Roussin, José Antonio Rueda-Camino, Pedro Ruiz‐Artacho, Sanjith Saseedharan, Ali Shamseddine, Gerald A. Soff, Hans Stricker, Vicky Tagalakis, Alì Taher, Toussaint Toutou, Javier Trujillo‐Santos, Stéphane Villiers, Raymond Wong, Norizaku Yamada
Safety of Proton Pump Inhibitors Based on a Large, Multi-Year, Randomized Trial of Patients Receiving Rivaroxaban or Aspirin
Paul Moayyedi, John W. Eikelboom, Jackie Bosch, Stuart J. Connolly, Leanne Dyal, Olga Shestakovska, Darryl P. Leong, Sonia S. Anand, Stefan Störk, Kelley R. Branch, Deepak L. Bhatt, Peter Verhamme, Martin O’Donnell, Aldo P. Maggioni, Eva Lonn, Leopoldo Soares Piegas, Georg Ertl, Mátyás Keltai, Nancy Cook Bruns, Eva Muehlhofer, Gilles R. Dagenais, Jae‐Hyung Kim, Masatsugu Hori, Philippe Gabríel Steg, Robert G. Hart, Rafael Díaz, Marco Alings, Petr Widimský, Álvaro Avezum, Jeffrey L. Probstfield, Jun Zhu, Yan Liang, Patricio López‐Jaramillo, Ajay K. Kakkar, Alexander Parkhomenko, Lars Rydén, Nana Pogosova, Antonio L Dans, Fernando Laņas, Patrick Commerford, Christian Torp‐Pedersen, Tomek J. Guzik, Dragoş Vinereanu, Andrew M. Tonkin, Basil S. Lewis, Camilo Félix, Khalid Yusoff, Kaj Metsärinne, Keith A.A. Fox, Salim Yusuf